Delivery Order 75N98024D00007-75N91024F00005
- Not listed
- The U.S. Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Firm Fixed Price Purchase Order to Beckman Coulter Inc. US Customer Operations Division for the CYTOFLEX LX SYSTEM. The $263,919.80 contract has a completion date of November 17, 2017. Beckman Coulter is a for-profit manufacturer of biomedical testing equipment and laboratory supplies, and has received numerous past awards from federal agencies such as the National Institute of...
- This federal contract award was made by the National Cancer Institute (NCI), a civilian agency, to Beckman Coulter, Inc., a for-profit manufacturer, to provide a Beckman-Coulter CytoFLEX S flow cytometer. The $192,588.20 firm-fixed-price purchase order was awarded on August 26, 2016, with an ultimate completion date of October 9, 2016. The contract was not set aside for any special designation. Beckman Coulter, a subsidiary of Danaher Corporation, is an experienced federal contractor that...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Beckman Coulter Inc. for $334,190.00. The award covers the purchase of Beckman Coulter CytoFLEX equipment, training, and related services. This includes a CytoFLEX LX flow cytometry system, plate loader, sample injection kit, installation, and an uninterruptible power supply. The contract does not have a set-aside designation....
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Beckman Coulter, Inc. in the amount of $24,378.00. The contract is for a service agreement to provide the Beckman Coulter CytoFLEX LX Base Instrument, which is used for biomedical testing and research. The award has an ultimate completion date of March 31, 2026. Beckman Coulter, a global manufacturer of biomedical testing equipment, is...
- This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Beckman Coulter Inc., a subsidiary of Danaher Corporation. The $52,132.90 firm fixed-price contract is for the upgrade of a CYTOFLEX S flow cytometry system from version 4-B2-Y0-R3 to version 4-B2-Y4-R3, including service and installation. This contract was not set aside for any small business category. Beckman Coulter is an experienced federal...
- The federal contract award is for preventative maintenance service on Beckman Cytoflex flow cytometry instruments for the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. The firm-fixed price contract was awarded to Beckman Coulter Inc., a global manufacturer of biomedical testing equipment and a subsidiary of Danaher Corporation. The contract has a ceiling value of $18,119.00 and a completion date of September 22, 2025. There was no set-aside designation used for...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Beckman Coulter, Inc., a global manufacturer of biomedical testing equipment, laboratory instruments, reagents, and related services. The contract is for the service coverage renewal of a CytoFLEX S chassis assembly that is used and maintained by the Molecular and Cellular Immunology Section (MCIS) of the...
- This is a one-year firm fixed price delivery order awarded by the National Institute of Alcoholism and Alcohol Abuse (NIAAA), a component of the National Institutes of Health (NIH), to Beckman Coulter Inc. for a service agreement to provide a CytoFLEX base instrument. The order has a ceiling value of $17,310.00 and no set-aside designation. Beckman Coulter Inc. is a subsidiary of Danaher Corporation, a global science and technology company, and serves as a prime contractor and subcontractor on...
- This federal contract award is for $105,426.00 to Beckman Coulter, Inc.'s US Customer Operations Division, a for-profit organization that provides advanced medical diagnostic products and services. The contract, designated as CYTOFLEX: 19-009375, was awarded on August 5, 2019 by the National Institutes of Health (NIH) National Institute on Drug Abuse, with a completion date of September 5, 2019. The contract is a firm fixed-price purchase order and does not have a set-aside designation....
- This is a $20,554.00 firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Beckman Coulter, Inc., a for-profit manufacturer of biomedical testing equipment and laboratory instruments. The contract is for the provision of a BECKMAN CYTOFLEX S FACS ANALYSIS MACHINE and associated services for a one-year period from July 1, 2025 to June 30, 2026. The contract does not have a small business set-aside designation, indicating Beckman...
- 75N98024D00007Indefinite Delivery Contract
- 75N98024D00007-75N91024F00005Delivery Order
This federal contract award is for the SERVICE CYTOFLEX S CHASSIS ASSEMBLY USA, with a potential value of $19,575.00. The prime contractor is Beckman Coulter Inc., through its US Customer Operations Division. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute. The contract has no set-aside designation. Beckman Coulter is a subsidiary of Danaher Corporation and a manufacturer of biomedical testing instruments, reagents, software, and related equipment and services. The company has extensive experience fulfilling federal government requirements for biomedical research, testing, and healthcare initiatives across various agencies, including the NIH, Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), and Department of Defense (DoD).
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.6k | 6/3/24 |